| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
| filingDate |
2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ed94b440aff659223a8f22d6dcc6ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f1242ae7146b6badc9bc6c9008134d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0fa755ad4ac23fea9527f1ca8aaac1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_701c0b2d051d7bf0b157e86138149743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1ef013b1dc1ac01abb9691da8d5f170
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59dacba4199f2a7c5c8adfb9776e9d43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce2cdeb10874d7c7ef03e927e515c02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5a88ae1dcefee065ed5668f48c874f |
| publicationDate |
2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090005271-A |
| titleOfInvention |
Crystalline bepotastine metal salt hydrate, preparation method thereof and pharmaceutical composition comprising the same |
| abstract |
The present invention relates to bepotastine metal salt hydrate of the crystalline form represented by the following formula (1), a method for preparing the same and a pharmaceutical composition comprising the same. The crystalline bepotastine metal salt hydrate according to the present invention is non-hygroscopic and very stable optically. It can be usefully used as an active ingredient of pharmaceutical compositions for antihistamines and anti-allergy.n n n <Formula 1>n n n n n n n n Wherein M is calcium or strontium. |
| priorityDate |
2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |